Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0900
+0.0020 (2.27%)
Jun 17, 2026, 4:35 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 108.02 million as of June 17, 2026. Its market cap has increased by 7.58% in one year.
Market Cap
108.02M
Enterprise Value
115.58M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 108.02M, a decrease of -85.92%. That is a compound annual growth rate of -45.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 108.02M | -5.78% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.27T |
| Genmab | 99.40B |
| Coloplast | 86.22B |
| ALK-Abelló | 59.91B |
| Gubra | 5.90B |
| BioPorto | 584.23M |
| ViroGates | 93.75M |
| Scandinavian Medical Solutions | 78.69M |